#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Colorectal cancer metastatic Obesity Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Congenital disorder of glycosylation Congenital nephrogenic diabetes insipidus Mucopolysaccharidosis III Dilated cardiomyopathy Hyperchylomicronaemia Chronic hepatitis B Drug eruption Osteosarcoma metastatic Biotinidase deficiency Rhabdomyosarcoma recurrent Breast angiosarcoma metastatic Arginase deficiency Chronic graft versus host disease in liver HER2 gene amplification Non-Hodgkin's lymphoma refractory More trials…

    Learn about Rare Diseases

    Idiopathic inflammatory myopathy Medulloblastoma – Treatment Ewing’s sarcoma metastatic – Trials in Disease Pulmonary sarcoidosis – Diagnostics Encephalitis autoimmune – Diagnostics Synovial sarcoma metastatic – Treatment IgA nephropathy – Treatment Krabbe’s disease Burkitt’s lymphoma – Trials in Disease Familial amyotrophic lateral sclerosis – Trials in Disease More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    MORPHINE Sirolimus Acasunlimab Granisetron Rbl005.3 Lasmiditan Ecopipam Hydrochloride Ephedrine Hydrochloride Tipapkinogene Sovacivec Ptg-Carcik-Cd19 Vortioxetine Cefoxitin Sodium KETOROLAC TROMETAMOL Pritelivir Clazakizumab Concizumab Ziclumeran Levodropropizine Vemurafenib Nomegestrol Acetate More therapies…

    Learn about Your Condition

    Malabsorption Arterial tortuosity syndrome Leber's congenital amaurosis Chronic sinusitis Haematological infection Haemodynamic instability Immunodeficiency congenital Septic shock White matter lesion Laparotomy Pneumonia bacterial Von Hippel-Lindau disease Choroidal dystrophy Nephrotic syndrome Anxiety More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Vaccine

  • A Study Comparing Melatonin versus Placebo for Mood Stabilization in Patients with Bipolar Disorder

    Recruiting

    3 1 1
    Investigated Diseases:
    • Bipolar disorder
    Investigated Drugs:
    • Melatonin
    • Placebo
    Denmark

  • A study testing capsaicin patches compared to placebo for patients with painful diabetic nerve damage to assess effects on nerve symptoms and nerve fibers

    Recruiting

    2 1 1
    Investigated Diseases:
    • Diabetic neuropathy
    Investigated Drugs:
    • Capsaicin
    Germany

  • A Study Testing the Safety of IRL757 in Adults with Parkinson’s Disease Who Have Apathy

    Recruiting

    1 1
    Investigated Diseases:
    • Parkinson’s disease
    Bulgaria Germany Poland Spain

  • Study of Heart and Blood Vessel Side Effects in Cancer Patients Receiving Immune Checkpoint Inhibitor Drug Combination Treatment

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Head and neck cancer
    • Malignant melanoma
    • Bladder cancer
    Investigated Drugs:
    • Atezolizumab
    • Durvalumab
    • Ipilimumab
    Hungary

  • A Study of Visugromab Compared to Placebo in Patients with Cancer-Related Cachexia to Test How Well It Works and How Safe It Is

    Recruiting

    4 1
    Investigated Diseases:
    • Cachexia
    Investigated Drugs:
    • VISUGROMAB
    Bulgaria Czechia France Germany Ireland Italy +5

  • Sodium-glucose cotransporter-2 inhibitor drug combination for patients with diabetes and heart attack to slow coronary artery disease progression

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Diabetes mellitus
    • Acute myocardial infarction
    Investigated Drugs:
    • Canagliflozin
    • Empagliflozin
    • Dapagliflozin
    Italy
Previous Page
1 … 79 80 81 82 83 … 1,646
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!